These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2531191)

  • 1. [In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma].
    Ueda M; Misaki O; Yamada T; Okamoto Y; Goto M; Maeda T; Okamura S; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1423-30. PubMed ID: 2531191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on oral-adjuvant chemotherapy of uterine cervical cancer after surgical treatment].
    Maeda T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1515-26. PubMed ID: 3095465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil.
    Ueda M; Kumagai K; Ueki K; Inoki C; Orino I; Ueki M
    Int J Cancer; 1997 May; 71(4):668-74. PubMed ID: 9178824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
    Suzuki M; Sekiguchi I; Ohwada M; Tamada T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E; Zinn S; Boarman D; Allegra CJ
    Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of epidermal growth factor (EGF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4.
    Ueda M; Ueki M; Sugimoto O
    Hum Cell; 1993 Sep; 6(3):218-25. PubMed ID: 8297819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA.
    Chu E; Lai GM; Zinn S; Allegra CJ
    Mol Pharmacol; 1990 Sep; 38(3):410-7. PubMed ID: 2402230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
    Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cells.
    Qin B; Tanaka R; Ariyama H; Shibata Y; Arita S; Kusaba H; Baba E; Harada M; Nakano S
    Anticancer Drugs; 2006 Apr; 17(4):439-43. PubMed ID: 16550002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
    Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
    Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of preoperative oral 5-fluorouracil on cell cycle of advanced cervical squamous cell carcinoma].
    Kondoh H; Niwa K; Itoh N; Murase T; Morishita S; Imai A; Tamaya T
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):893-7. PubMed ID: 8678538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EGF receptor and effects of EGF on growth and tumor marker secretion in uterine cervical cancer cells].
    Ueda M; Okamoto Y; Yamada T; Misaki O; Tsurunaga T; Iwai E; Yanagawa Y; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1700-6. PubMed ID: 3266224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
    Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.